2023 Life Sciences Industry and Real Estate Perspective: Part 2

In this report, we assess the future landscape for biopharma, medtech and biomanufacturing looking specifically at real estate investors and life science companies. This year, JLL has also ranked the top medtech and biomanufacturing markets by applying a concentrated analysis to our model. We emphasized metrics specific to the two subsectors to determine which markets show strength when narrowing in the focus on medtech and biomanufacturing.

Key Topics:

1. Where are the opportunities in a challenging time?
2. How do the 2023 life sciences markets stack up?
3. What are the top medtech and biomanufacturing markets?
4. What does this all mean?

Click here to read Part 1 of this report, where you will cultivate a deeper level of understanding of what makes a healthy and vibrant life sciences ecosystem and the critical role real estate.